• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccine . Influenza vaccine delivery models in secondary care (hospital) settings: What approaches are used to enhance access for clinical risk grou

tetano

Editor, Senior Moderator
Vaccine


. 2025 Jul 5:62:127445.
doi: 10.1016/j.vaccine.2025.127445. Online ahead of print. Influenza vaccine delivery models in secondary care (hospital) settings: What approaches are used to enhance access for clinical risk groups in England?

Rajeka Lazarus[SUP] 1 [/SUP], Ben Kasstan-Dabush[SUP] 2 [/SUP], Ifra Ali[SUP] 2 [/SUP], Sandra Mounier-Jack[SUP] 2 [/SUP]



Affiliations
Abstract

Background: Influenza vaccine uptake rates in England remain suboptimal among adults with clinical conditions that predispose to severe influenza. Influenza vaccines are predominantly delivered in primary care settings, but complementary delivery via a broader range of secondary care settings is recommended to enhance access. This qualitative study aimed to document current influenza vaccine delivery models in hospital-based settings and to compare the opportunities and limitations associated with those delivery models.
Methods: Semi-structured interviews (n = 28) were conducted with healthcare professionals based in secondary care, and with National Health Service commissioners to understand current vaccine delivery practices within hospital settings in two regions of England.
Results: Most hospitals who offered patient vaccination had invested in dedicated staff and processes to support influenza vaccine delivery. A variety of interventions were used to navigate the steps in the vaccination pathway. Challenges included engagement of medical staff, access to vaccination records and managing vaccine stocks.
Conclusion: Secondary care vaccination is possible with the appropriate investment in staff and processes. Focusing on staff engagement, addressing logistic challenges and providing adequate invesment would support the sustainability of vaccination in secondary care.


 
Back
Top Bottom